Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05924932
Status:
RECRUITING
Last Update Posted:
2023-11-03
First Post:
2023-06-21
Brief Title:
Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D
Sponsor:
Masaryk Hospital Usti nad Labem
Organization:
Masaryk Hospital Usti nad Labem
Study Overview
Official Title:
Effect of an Artificial Pancreas System on Glycemic Control in Patients With Type 1 Diabetes
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is compare the effect of hybrid closed loop system HCL for automatic insulin dosing treatment on the glycemic control of type 1 diabetes T1D in patient with different initial glycated hemoglobin
Detailed Description:
Rationale for the Study
According to our hypothesis even T1D patients with an initially optimal glucose level should benefit from this treatment method in the form of a reduction in glycemic variability
There are very few clinical studies from real practice in a larger group of patients
According to our hypothesis even T1D patients with an initially optimal glucose level should benefit from this treatment method in the form of a reduction in glycemic variability
There are very few clinical studies from real practice in a larger group of patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None